Nucala is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Mepolizumab.
Product ID | 0173-0892_446a68b1-6766-4906-8419-b203b17c429e |
NDC | 0173-0892 |
Product Type | Human Prescription Drug |
Proprietary Name | Nucala |
Generic Name | Mepolizumab |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2019-06-06 |
Marketing Category | BLA / BLA |
Application Number | BLA761122 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | MEPOLIZUMAB |
Active Ingredient Strength | 100 mg/mL |
Pharm Classes | Interleukin-5 Antagonist [EPC],Interleukin-5 Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-06-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA761122 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-06-06 |
Marketing Category | BLA |
Application Number | BLA761122 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-06-06 |
Marketing Category | BLA |
Application Number | BLA761122 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-06-06 |
Marketing Category | BLA |
Application Number | BLA761122 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-06-06 |
Ingredient | Strength |
---|---|
MEPOLIZUMAB | 100 mg/mL |
SPL SET ID: | fefb887c-e4ac-431e-8893-e9d1a5a63fea |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0173-0881 | Nucala | mepolizumab |
0173-0892 | Nucala | mepolizumab |
0173-0904 | Nucala | mepolizumab |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() NUCALA 97086351 not registered Live/Pending |
Xie, Wenfu 2021-10-21 |
![]() NUCALA 86293514 4900162 Live/Registered |
Glaxo Group Limited 2014-05-28 |
![]() NUCALA 85371627 4714559 Live/Registered |
Glaxo Group Limited 2011-07-14 |